project id: TCGA-STAD; case submitter id: TCGA-B7-A5TI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 7.5; age at index: 52; days to birth: -19014; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 19014; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 595.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 58; initial weight: 240.0; sample id: e3aeb5a8-26f9-4401-b53e-0638fbda8dbb; sample submitter id: TCGA-B7-A5TI-01A; portion id: be498e61-2f32-4682-a566-cc17d3851b5c; portion submitter id: TCGA-B7-A5TI-01A-11; slide id: ee4b83f4-27ad-4d83-aeac-a452a5ec85f8; slide submitter id: TCGA-B7-A5TI-01A-01-TSA; percent lymphocyte infiltration: 6.0; percent monocyte infiltration: 2.0; percent necrosis: 13.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 62.0; percent tumor cells: 25.0; percent tumor nuclei: 70.0; section location: TOP;